Related Experiment Video
Updated: May 9, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Extracellular microRNAs in urologic malignancies: chances and challenges
Xiaoyi Huang1, Meihua Liang, Rachel Dittmar
1Department of Pathology and Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Extracellular microRNAs (miRNAs) are key players in cell communication and cancer. These stable molecules in body fluids show promise as diagnostic and prognostic biomarkers for urologic cancers.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs crucial in biological mechanisms, including carcinogenesis.
- Extracellular miRNAs, protected by proteins or microvesicles, facilitate cell-cell communication.
- Their stability in body fluids positions them as potential disease biomarkers and therapeutic agents.
Purpose of the Study:
- To review miRNA biogenesis and characteristics.
- To summarize extracellular miRNA profiling in prostate, bladder, and renal cell carcinoma.
- To discuss the diagnostic, prognostic, and therapeutic potential of extracellular miRNAs in urologic cancers.
Main Methods:
- Literature review of recent publications on extracellular miRNA profiling.
- Focus on studies utilizing biological fluids like serum, plasma, and urine.
- Analysis of miRNA roles in prostate, bladder, and renal cell carcinoma.
Main Results:
- Extracellular miRNAs are involved in cell-cell communication and cancer development.
- Profiling studies reveal specific miRNA signatures in urologic cancers.
- Evidence supports their diagnostic and prognostic value in serum, plasma, and urine.
Conclusions:
- Extracellular miRNAs are promising biomarkers for urologic cancer diagnosis and prognosis.
- Further research is needed to overcome challenges in clinical applications.
- Their therapeutic potential warrants continued investigation.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019